The latter defect increases the risk for hypoglycemia during insulin therapy or following insulin secretagogue treatment, and is one of the major factors of frailty in people with diabetes, especially when associated with reduced adrenaline response and with loss of symptoms to hypoglycemia (unawareness). Here, INS is linked to Hypoglycemia.